These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24803356)

  • 1. [5ARI and PSA: evidences].
    Morgia G; Urzì D; Russo GI
    Urologia; 2014 Sep; 81 Suppl 24():4-11. PubMed ID: 24803356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific antigen prostatic changes during treatment with finasteride or dutasteride for benign prostatic hyperplasia].
    Arena F
    Minerva Urol Nefrol; 2013 Sep; 65(3):211-6. PubMed ID: 23872632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5ARI and PSA: therapeutic aspects].
    Sciarra A
    Urologia; 2014 Sep; 81 Suppl 24():17-20. PubMed ID: 24744217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.
    Andriole GL; Marberger M; Roehrborn CG
    J Urol; 2006 May; 175(5):1657-62. PubMed ID: 16600723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-alpha-reductase Inhibitors for prostate cancer prevention.
    Wilt TJ; MacDonald R; Hagerty K; Schellhammer P; Kramer BS
    Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD007091. PubMed ID: 18425978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison in the follow-up of two patients with persistent elevated PSA and negative prostate biopsy].
    Sciarra A; Panebianco V
    Urologia; 2014; 81(1):60-3. PubMed ID: 24585440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level.
    Lin VC; Liao CH; Wang CC; Kuo HC
    J Formos Med Assoc; 2015 Sep; 114(9):865-71. PubMed ID: 24064231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of finasteride on prostate specific antigen: review of available data.
    Guess HA; Gormley GJ; Stoner E; Oesterling JE
    J Urol; 1996 Jan; 155(1):3-9. PubMed ID: 7490873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy.
    Heo JE; Koo KC; Hong SJ; Park SU; Chung BH; Lee KS
    Yonsei Med J; 2018 Mar; 59(2):219-225. PubMed ID: 29436189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
    Montorsi F; Alcaraz A; Desgrandchamps F; Hammerer P; Schröder F; Castro R
    Prostate; 2009 Jun; 69(8):895-907. PubMed ID: 19267353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sexual function after dutasteride treatment in patients with once-negative prostate biopsy and benign prostate hyperplasia.
    Taniguchi H; Inoue T; Kawa G; Murota T; Tsukino H; Yoshimura K; Kamoto T; Ogawa O; Matsuda T; Kinoshita H
    Urologia; 2023 May; 90(2):295-300. PubMed ID: 36992564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
    Pirozzi L; Sountoulides P; Castellan P; Presicce F; Lombardo R; Romero M; De Nunzio C; Tubaro A; Schips L; Cindolo L
    Curr Drug Targets; 2015; 16(11):1165-71. PubMed ID: 25981606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen increase during dutasteride to indicate the need for prostate biopsy: influence of prostatic inflammation.
    Sciarra A; Maggi M; Fasulo A; Salciccia S; Gentile V; Cattarino S; Gentilucci A
    Urologia; 2017 Aug; 84(3):158-164. PubMed ID: 28430341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
    Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Role for Preoperative 5 Alpha Reductase Inhibitors in Reducing Prostate Vascularity and Blood Loss?
    Bruha M; Welliver C
    Curr Urol Rep; 2017 Oct; 18(10):75. PubMed ID: 28766115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between prostate-specific antigen density and prostatic shrinkage in response to finasteride therapy.
    Kirschenbaum A; Pacheco E; Schuval BJ; Levine AC
    World J Urol; 1996; 14(6):360-2. PubMed ID: 8986036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications and surgical interventions for benign prostatic hyperplasia are potential confounders of prostate-specific antigen.
    Modi P; Helfand BT; McVary KT
    Curr Urol Rep; 2010 Jul; 11(4):224-7. PubMed ID: 20467844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.